Cargando…

Autoimmune septin-5 cerebellar ataxia

OBJECTIVE: To report a form of autoimmune cerebellar ataxia in which antibodies target septin-5, a guanosine triphosphate (GTP)-binding neural protein involved in neurotransmitter exocytosis. METHODS: Archived sera and CSF specimens with unclassified synaptic antibodies were re-evaluated by tissue-b...

Descripción completa

Detalles Bibliográficos
Autores principales:	Honorat, Josephe A., Lopez-Chiriboga, A. Sebastian, Kryzer, Thomas J., Fryer, James P., Devine, Michelle, Flores, Angela, Lennon, Vanda A., Pittock, Sean J., McKeon, Andrew
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039209/ https://www.ncbi.nlm.nih.gov/pubmed/29998156 http://dx.doi.org/10.1212/NXI.0000000000000474

Ejemplares similares

Autoimmune gait disturbance accompanying adaptor protein-3B2-IgG
por: Honorat, Josephe A., et al.
Publicado: (2019)

Autoimmune Septin-5 Cerebellar Ataxia
Publicado: (2018)

Signal recognition particle immunoglobulin g detected incidentally associates with autoimmune myopathy
por: Apiwattanakul, Metha, et al.
Publicado: (2016)

Contactin-1 autoimmunity: Serologic, neurologic, and pathologic correlates
por: Dubey, Divyanshu, et al.
Publicado: (2020)

Phosphodiesterase 10A IgG: A novel biomarker of paraneoplastic neurologic autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2019)

Episodic ataxia in CASPR2 autoimmunity
por: López Chiriboga, A. Sebastian, et al.
Publicado: (2018)

Septin-3 autoimmunity in patients with paraneoplastic cerebellar ataxia
por: Miske, Ramona, et al.
Publicado: (2023)

Neurochondrin neurological autoimmunity
por: Shelly, Shahar, et al.
Publicado: (2019)

Clinical utility of testing AQP4-IgG in CSF: Guidance for physicians
por: Majed, Masoud, et al.
Publicado: (2016)

Paraneoplastic neuronal intermediate filament autoimmunity
por: Basal, Eati, et al.
Publicado: (2018)

ITPR1 autoimmunity: Frequency, neurologic phenotype, and cancer association
por: Alfugham, Nora, et al.
Publicado: (2017)

IgLON5 antibody: Neurological accompaniments and outcomes in 20 patients
por: Honorat, Josephe A., et al.
Publicado: (2017)

IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel
por: Lennon, Vanda A., et al.
Publicado: (2005)

Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders
por: Hinson, Shannon R., et al.
Publicado: (2018)

Autoimmune Encephalitis Criteria in Clinical Practice
por: Orozco, Emma, et al.
Publicado: (2023)

Randomized Placebo‐Controlled Trial of Intravenous Immunoglobulin in Autoimmune LGI1/CASPR2 Epilepsy
por: Dubey, Divyanshu, et al.
Publicado: (2019)

Population-Based Epidemiology Study of Paraneoplastic Neurologic Syndromes
por: Shah, Shailee, et al.
Publicado: (2021)

Brain dysfunction and thyroid antibodies: autoimmune diagnosis and misdiagnosis
por: Valencia-Sanchez, Cristina, et al.
Publicado: (2021)

Aquaporin-4–binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by down-regulating EAAT2
por: Hinson, Shannon R., et al.
Publicado: (2008)

Diagnostic value of aquaporin-4-IgG live cell based assay in neuromyelitis optica spectrum disorders
por: Redenbaugh, Vyanka, et al.
Publicado: (2021)

A comparison of tissue-based and recombinant protein–based assays for detecting PCA-Tr/DNER-IgG
por: Alfugham, Nora, et al.
Publicado: (2016)

Treatment of Primary Autoimmune Cerebellar Ataxia with Mycophenolate
por: Hadjivassiliou, M., et al.
Publicado: (2020)

Case report: Anti septin-5-encephalitis as a treatable cause of cerebellar ataxia and psychiatric symptoms
por: Wischmann, Johannes, et al.
Publicado: (2023)

GABA(A) receptor autoimmunity: A multicenter experience
por: O'Connor, Kevin, et al.
Publicado: (2019)

Consensus Paper: Latent Autoimmune Cerebellar Ataxia (LACA)
por: Manto, Mario, et al.
Publicado: (2023)

Diagnostic Criteria for Primary Autoimmune Cerebellar Ataxia—Guidelines from an International Task Force on Immune-Mediated Cerebellar Ataxias
por: Hadjivassiliou, Marios, et al.
Publicado: (2020)

Cerebellar Ataxia in the Setting of Hashimoto’s Thyroiditis: A Case Report Update and Review
por: Chiriboga Reyes, Gustavo, et al.
Publicado: (2023)

Antiepileptic drug therapy in autoimmune epilepsy associated with antibodies targeting the leucine‐rich glioma‐inactivated protein 1
por: Feyissa, Anteneh M., et al.
Publicado: (2018)

Elevated LGI1‐IgG CSF index predicts worse neurological outcome
por: Gadoth, Avi, et al.
Publicado: (2018)

Autoimmune Encephalitis Misdiagnosis in Adults
por: Flanagan, Eoin P., et al.
Publicado: (2022)

Update in Autoimmune Movement Disorders: Newly Described Antigen Targets in Autoimmune and Paraneoplastic Cerebellar Ataxia
por: Garza, Madeline, et al.
Publicado: (2021)

Treatable cerebellar ataxias()
por: K.P., Divya, et al.
Publicado: (2020)

The underpinnings of cerebellar ataxias
por: Manto, Mario
Publicado: (2022)

Posttransplant autoimmune encephalitis
por: Cohen, Devon A., et al.
Publicado: (2018)

Neuronal intermediate filament IgGs in CSF: Autoimmune Axonopathy Biomarkers
por: McKeon, Andrew, et al.
Publicado: (2020)

Clinical Recognition of Sensory Ataxia and Cerebellar Ataxia
por: Zhang, Qing, et al.
Publicado: (2021)

Steroid-responsive Encephalopathy Associated with Autoimmune Thyroiditis (SREAT) Presenting with Pure Cerebellar Ataxia
por: Termsarasab, Pichet, et al.
Publicado: (2018)

Aquaporin-4 autoimmunity
por: Zekeridou, Anastasia, et al.
Publicado: (2015)

Cerebellar ataxia with sensory ganglionopathy; does autoimmunity have a role to play?
por: Zis, Panagiotis, et al.
Publicado: (2017)

Positive Predictive Value of Myelin Oligodendrocyte Glycoprotein Autoantibody Testing
por: Sechi, Elia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_oijhbqh0spa5lgufbih384re5f